Search results
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...
Morningstar· 5 days ago(Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan designation for QALSODY® (tofersen) for the treatment ...
Guest column: With FDA approval of software treatment for depression, the digital medicine...
WRAL TechWire· 5 days agoIn a watershed moment for digital health innovation, the FDA recently granted clearance to Rejoyn, a...
7 of this week's most noteworthy health stories, in case you missed them
Fox News· 3 days agoFox News Digital publishes a range of health pieces every day of the week to keep you up-to-date on...
Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting...
Morningstar· 3 days agoLUND, SWEDEN / ACCESSWIRE / June 1, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today gave a presentation at the ASCO conference showing clinical data on nadunolimab counteracting the serious problem of chemotherapy